1
Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population
Condition(s):Urothelial CarcinomaLast Updated:July 15, 2022Completed
Carcinoma, Transitional Cell: 842 Clinical Trials, Page 1 of 85
Hide Studies Not Open or Pending
2
Vasculogenic Mimicry in Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:March 5, 2020Unknown status
3
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
Condition(s):Urothelial Carcinoma; Bladder CancerLast Updated:March 20, 2020Unknown status
4
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:May 24, 2022Active, not recruiting
5
Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Condition(s):Carcinoma, Transitional CellLast Updated:February 14, 2022Completed
6
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:August 19, 2015Withdrawn
7
A Study to Learn About First-line Avelumab Maintenance in Japanese Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:July 22, 2022Not yet recruiting
8
Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma
Condition(s):Urinary Bladder Urothelial CarcinomaLast Updated:July 29, 2022Recruiting
9
A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up
Condition(s):Urothelial CarcinomaLast Updated:September 16, 2021Recruiting
10
DNA Methylation and Urothelial Carcinoma
Condition(s):Urothelial CarcinomaLast Updated:June 22, 2011Unknown status